NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/04/2025
Back to search
Official data from USPTO
BLIFASEND
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
11/04/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
03/26/2025
Registration date
11/04/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/04/2025
Last transaction
11/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Stevenage, GB
Examiner
SNYDER,NELSON B
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Glaxo Group Limited
Representatives
Christopher M. Hanes GSK
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissuepaininflammationobesityinfectious diseases; Pharmaceutical preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryoncologicalhepatologicalhematologicalbacterialrespiratoryneurologicalgastrointestinaldermatologicalpsychiatricimmune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/16/2025
PUBO
PUBLISHED FOR OPPOSITION
09/16/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/15/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/14/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/14/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/14/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/08/2025
GNSL
LETTER OF SUSPENSION E-MAILED
08/08/2025
CNSL
SUSPENSION LETTER WRITTEN
08/08/2025
DOCK
ASSIGNED TO EXAMINER
08/07/2025
MAFR
APPLICATION FILING RECEIPT MAILED
03/26/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/26/2025
NWAP
NEW APPLICATION ENTERED
03/26/2025
Continuous trademark protection
Get notified about every new filing that threatens BLIFASEND or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.